Global Small Nucleic Acid Drug Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Small Nucleic Acid Drug market size will reach 7,777.42 Million USD in 2025 and is projected to reach 25,308.72 Million USD by 2032, with a CAGR of 18.36% (2025-2032). Notably, the China Small Nucleic Acid Drug market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Small nucleic acid drugs are a class of therapeutic agents that target specific sequences of RNA or DNA to regulate gene expression and modulate biological processes at the molecular level. These drugs, including antisense oligonucleotides, small interfering RNA (siRNA), and messenger RNA (mRNA) therapeutics, are designed to bind to their target nucleic acids and either block the production of harmful proteins or correct genetic defects. Small nucleic acid drugs have gained significant attention for their potential to treat a wide range of diseases, including genetic disorders, viral infections, and cancer, by precisely targeting the root cause of the disease at the genetic level. These drugs offer a novel and highly specific approach to therapy, with the ability to treat conditions that were previously difficult or impossible to address with traditional small-molecule drugs.
The major global suppliers of Small Nucleic Acid Drug include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, AstraZeneca, Novo Nordisk, Astellas Pharma, Geron Corporation, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Small Nucleic Acid Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Small Nucleic Acid Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Small Nucleic Acid Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Small Nucleic Acid Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Small Nucleic Acid Drug Include:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
Jazz Pharmaceuticals
AstraZeneca
Novo Nordisk
Astellas Pharma
Geron Corporation
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Small Nucleic Acid Drug Product Segment Include:
Antisense Oligonucleotides (ASO)
siRNA
Others
Small Nucleic Acid Drug Product Application Include:
Neuromuscular Diseases
hATTR
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Small Nucleic Acid Drug Industry PESTEL Analysis
Chapter 3: Global Small Nucleic Acid Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Small Nucleic Acid Drug Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Small Nucleic Acid Drug Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Small Nucleic Acid Drug Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Small Nucleic Acid Drug Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Small Nucleic Acid Drug market size will reach 7,777.42 Million USD in 2025 and is projected to reach 25,308.72 Million USD by 2032, with a CAGR of 18.36% (2025-2032). Notably, the China Small Nucleic Acid Drug market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Small nucleic acid drugs are a class of therapeutic agents that target specific sequences of RNA or DNA to regulate gene expression and modulate biological processes at the molecular level. These drugs, including antisense oligonucleotides, small interfering RNA (siRNA), and messenger RNA (mRNA) therapeutics, are designed to bind to their target nucleic acids and either block the production of harmful proteins or correct genetic defects. Small nucleic acid drugs have gained significant attention for their potential to treat a wide range of diseases, including genetic disorders, viral infections, and cancer, by precisely targeting the root cause of the disease at the genetic level. These drugs offer a novel and highly specific approach to therapy, with the ability to treat conditions that were previously difficult or impossible to address with traditional small-molecule drugs.
The major global suppliers of Small Nucleic Acid Drug include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, Jazz Pharmaceuticals, AstraZeneca, Novo Nordisk, Astellas Pharma, Geron Corporation, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Small Nucleic Acid Drug. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Small Nucleic Acid Drug market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Small Nucleic Acid Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Small Nucleic Acid Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Small Nucleic Acid Drug Include:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
Jazz Pharmaceuticals
AstraZeneca
Novo Nordisk
Astellas Pharma
Geron Corporation
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Small Nucleic Acid Drug Product Segment Include:
Antisense Oligonucleotides (ASO)
siRNA
Others
Small Nucleic Acid Drug Product Application Include:
Neuromuscular Diseases
hATTR
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Small Nucleic Acid Drug Industry PESTEL Analysis
Chapter 3: Global Small Nucleic Acid Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Small Nucleic Acid Drug Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Small Nucleic Acid Drug Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Small Nucleic Acid Drug Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Small Nucleic Acid Drug Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Small Nucleic Acid Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Small Nucleic Acid Drug Product by Type
- 1.2.1 Antisense Oligonucleotides (ASO)
- 1.2.2 siRNA
- 1.2.3 Others
- 1.3 Small Nucleic Acid Drug Product by Application
- 1.3.1 Neuromuscular Diseases
- 1.3.2 hATTR
- 1.3.3 Others
- 1.4 Global Small Nucleic Acid Drug Market Size Analysis (2020-2032)
- 1.5 Small Nucleic Acid Drug Market Development Status and Trends
- 1.5.1 Small Nucleic Acid Drug Industry Development Status Analysis
- 1.5.2 Small Nucleic Acid Drug Industry Development Trends Analysis
- 2 Small Nucleic Acid Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Small Nucleic Acid Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Small Nucleic Acid Drug Market Analysis by Country
- 4.1 Global Small Nucleic Acid Drug Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Small Nucleic Acid Drug Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Small Nucleic Acid Drug Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.5 China Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.6 France Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.14 India Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Small Nucleic Acid Drug Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Small Nucleic Acid Drug Market Revenue by Key Suppliers (2021-2025)
- 5.2 Small Nucleic Acid Drug Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Small Nucleic Acid Drug Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Small Nucleic Acid Drug Market Analysis by Type
- 6.1 Global Small Nucleic Acid Drug Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Small Nucleic Acid Drug Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sarepta Therapeutics
- 7.1.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sarepta Therapeutics Small Nucleic Acid Drug Product Portfolio
- 7.1.3 Sarepta Therapeutics Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Ionis Pharmaceuticals
- 7.2.1 Ionis Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Ionis Pharmaceuticals Small Nucleic Acid Drug Product Portfolio
- 7.2.3 Ionis Pharmaceuticals Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Alnylam
- 7.3.1 Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Alnylam Small Nucleic Acid Drug Product Portfolio
- 7.3.3 Alnylam Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Biogen
- 7.4.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Biogen Small Nucleic Acid Drug Product Portfolio
- 7.4.3 Biogen Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Nippon Shinyaku
- 7.5.1 Nippon Shinyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Nippon Shinyaku Small Nucleic Acid Drug Product Portfolio
- 7.5.3 Nippon Shinyaku Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Sobi
- 7.6.1 Sobi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Sobi Small Nucleic Acid Drug Product Portfolio
- 7.6.3 Sobi Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Novartis
- 7.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Novartis Small Nucleic Acid Drug Product Portfolio
- 7.7.3 Novartis Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Jazz Pharmaceuticals
- 7.8.1 Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Jazz Pharmaceuticals Small Nucleic Acid Drug Product Portfolio
- 7.8.3 Jazz Pharmaceuticals Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 AstraZeneca
- 7.9.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 AstraZeneca Small Nucleic Acid Drug Product Portfolio
- 7.9.3 AstraZeneca Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Novo Nordisk
- 7.10.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Novo Nordisk Small Nucleic Acid Drug Product Portfolio
- 7.10.3 Novo Nordisk Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Astellas Pharma
- 7.11.1 Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Astellas Pharma Small Nucleic Acid Drug Product Portfolio
- 7.11.3 Astellas Pharma Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Geron Corporation
- 7.12.1 Geron Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Geron Corporation Small Nucleic Acid Drug Product Portfolio
- 7.12.3 Geron Corporation Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 CureVac
- 7.13.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 CureVac Small Nucleic Acid Drug Product Portfolio
- 7.13.3 CureVac Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Regulus Therapeutics
- 7.14.1 Regulus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Regulus Therapeutics Small Nucleic Acid Drug Product Portfolio
- 7.14.3 Regulus Therapeutics Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 ProQR
- 7.15.1 ProQR Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 ProQR Small Nucleic Acid Drug Product Portfolio
- 7.15.3 ProQR Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 Secarna
- 7.16.1 Secarna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 Secarna Small Nucleic Acid Drug Product Portfolio
- 7.16.3 Secarna Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 MiNA Therapeutics
- 7.17.1 MiNA Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.2 MiNA Therapeutics Small Nucleic Acid Drug Product Portfolio
- 7.17.3 MiNA Therapeutics Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.18 Sylentis
- 7.18.1 Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.18.2 Sylentis Small Nucleic Acid Drug Product Portfolio
- 7.18.3 Sylentis Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.19 Arrowhead
- 7.19.1 Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.19.2 Arrowhead Small Nucleic Acid Drug Product Portfolio
- 7.19.3 Arrowhead Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.20 Silence Therapeutics
- 7.20.1 Silence Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.20.2 Silence Therapeutics Small Nucleic Acid Drug Product Portfolio
- 7.20.3 Silence Therapeutics Small Nucleic Acid Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Small Nucleic Acid Drug Industry Chain Analysis
- 8.2 Small Nucleic Acid Drug Product Downstream Application Analysis
- 8.2.1 Global Small Nucleic Acid Drug Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Small Nucleic Acid Drug Revenue and Forecast by Application (2020-2032)
- 8.3 Small Nucleic Acid Drug Typical Downstream Customers
- 8.4 Small Nucleic Acid Drug Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
